We report 2 cases of patients with solid tumors and coagulopathy who experienced avascular necrosis (AVN) of the bone following chemotherapy. Both cases exhibited nontraumatic bilateral AVN of the femoral heads, and one also showed bilateral AVN of the humeral heads. One case had multiple thromboembolic complications, including pulmonary obstructive syndrome and paraneoplastic pain. The other showed multiple paraneoplastic syndromes, with hypercalcemia and thrombocytosis. Groin pain and claudication of the lower extremities developed and persisted. Both patients eventually received bilateral hip arthroplasty due to AVN of both femoral heads.

Avascular necrosis (AVN) of the femoral head is a pathological process that results from disruption of the blood supply to the bone and occurs most commonly in the femoral epiphysis [1]. Patients usually present with pain and limited joint motion [1]. The risk factors are not completely understood [2, 3]. Nontraumatic necrosis of the femoral head was also mentioned [4, 5]. The mechanism involves impaired circulation to a specific area that ultimately becomes necrotic. Furthermore, coagulation disorders have been reported in patients with AVN of the femoral head [6]. AVN is most frequently associated with high doses of oral and intravenous corticosteroids and prolonged duration of therapy [7]. Cancer patients receiving chemotherapy are usually also treated with corticosteroids for the prophylaxis of emesis [8]. AVN of the humeral head has rarely been reported [9], although one case of bilateral AVN of the humeral heads has been reported in a patient with Hodgkin lymphoma following therapy [10].

We report 2 cases of cancer patients with coagulopathy following chemotherapy. The first was a patient with breast cancer and bilateral AVN of the femoral and humeral heads. The second was a patient with malignant thymoma and bilateral AVN of the femoral heads.

Case 1

Case 1 was a 54-year-old woman with recurrent bilateral breast cancer, who was hospitalized in July 2009 with dyspnea. Her chest X-rays showed no abnormalities, but the chest computed tomography (CT) scan showed a tumor or thrombus over the right pulmonary vein and entering the left atrium (Fig. 1a). The D-dimer value was 518 ng/mL (normal range < 500 ng/dL). The patient received chemotherapy with 5-fluorouracil, leucovorin, vinorelbine, and cisplatin every 4 weeks, as well as daily subcutaneous treatment with a low-molecular-weight heparin (LMWH), Fraxiparine (GlaxoSmithKline). The dyspnea improved during the chemotherapy course, but migrating pain, paraneoplastic pain, and swelling occurred over the left infra-auricular area. Dexamethasone was given for the prophylaxis of emesis and to improve the coagulation disorder.

Fig. 1.

Case 1 was a 54-year-old female with breast cancer who was receiving chemotherapy. a The chest CT scan (axial view) showed a tumor or thrombus (arrowhead) over the right posterior proximal pulmonary vein and entering the left atrium. b The plain X-ray revealed bilateral osteonecrosis of the femoral heads (arrows). c The pelvis CT scan (axial view) showed osteonecrosis of the right femoral head (arrow) after arthroplasty of the left hip joint.

Fig. 1.

Case 1 was a 54-year-old female with breast cancer who was receiving chemotherapy. a The chest CT scan (axial view) showed a tumor or thrombus (arrowhead) over the right posterior proximal pulmonary vein and entering the left atrium. b The plain X-ray revealed bilateral osteonecrosis of the femoral heads (arrows). c The pelvis CT scan (axial view) showed osteonecrosis of the right femoral head (arrow) after arthroplasty of the left hip joint.

Close modal

The patient complained of pain and numbness localized to the bilateral groin area, especially the left side, and from July 2012 had difficulty walking. The pelvis X-ray showed bilateral AVN of the femoral heads (Fig. 1b). Bipolar hip arthroplasty was performed on the left hip in September 2012 and on the right hip in November 2012. The CT scan showed osteonecrosis of the right femoral head after bipolar surgery had been performed on the left femoral head (Fig. 1c). Pathological specimens of both femoral heads showed AVN, but no cancer cells were seen.

The patient also complained of bilateral shoulder pain, especially on the left side. The plain X-ray showed osteonecrosis of both the humeral heads (Fig. 2a, b). The chest CT scan revealed bilateral osteonecrosis of the humeral heads, which was more severe on the left side (Fig. 2c).

Fig. 2.

Shoulder lesions of case 1. The plain X-ray revealed osteonecrosis of the right humeral head (arrow) (a) and the left humeral head (arrow) (b). c The chest CT scan (coronary view) showed bilateral osteonecrosis of the humeral heads (arrows), which was more severe on the left side.

Fig. 2.

Shoulder lesions of case 1. The plain X-ray revealed osteonecrosis of the right humeral head (arrow) (a) and the left humeral head (arrow) (b). c The chest CT scan (coronary view) showed bilateral osteonecrosis of the humeral heads (arrows), which was more severe on the left side.

Close modal

The patient received a total of 40 courses of chemotherapy. She complained of severe left chest pain from October 2014, and we suspected acute coronary syndrome related to cancer with coagulopathy. The chest X-ray revealed cardiomegaly, and echocardiography showed a large quantity of pericardial effusion. The patient died of tumor progression and brain death in November 2014.

Case 2

Case 2 was a 51-year-old man with malignant thymoma, who was hospitalized in 2012 with dyspnea. He also exhibited paraneoplastic syndromes with hypercalcemia (serum calcium 12.4 mg/dL, normal range 7.9–9.9 mg/dL) and thrombocytosis (platelet count 824 × 103/µL, normal range 50–450 × 103/µL). His D-dimer value was > 10,000 ng/mL (normal range < 500 ng/dL). The chest X-ray and CT scan revealed a large anterior mediastinal mass (Fig. 3a). The patient received chemotherapy with 5-fluorouracil, leucovorin, and cisplatin every 4 weeks as well as daily subcutaneous treatment with an LMWH, enoxaparin (Sanofi-Aventis). Dexamethasone was given for the prophylaxis of emesis.

Fig. 3.

Case 2 was a 53-year-old male with malignant thymoma who was receiving chemotherapy. a The initial chest X-ray showed a large mediastinal mass. b The chest CT scan (axial view) revealed a tumor or thrombus over the right posterior proximal pulmonary vein and left atrium (arrowhead). c The pelvis X-ray showed bilateral osteonecrosis of the femoral heads (arrows).

Fig. 3.

Case 2 was a 53-year-old male with malignant thymoma who was receiving chemotherapy. a The initial chest X-ray showed a large mediastinal mass. b The chest CT scan (axial view) revealed a tumor or thrombus over the right posterior proximal pulmonary vein and left atrium (arrowhead). c The pelvis X-ray showed bilateral osteonecrosis of the femoral heads (arrows).

Close modal

The anterior mediastinal mass decreased in size following chemotherapy. The subsequent CT scan revealed this decrease as well as a tumor or thrombus over the right pulmonary vein and left atrium (Fig. 3b). The patient received regular chemotherapy but refused radiotherapy. An initial tumor response was noted; however, later this lesion progressed.

The patient complained of pain localized to the groin area and difficulty in walking in November 2012. The pelvis X-ray revealed bilateral AVN of the femoral heads (Fig. 3c). Bipolar hip arthroplasty was performed on the left hip in January 2013 and on the right hip in April 2013. Pathological specimens of both femoral heads showed AVN, but no cancer cells were seen. The patient received a total of 10 courses of chemotherapy, but died of tumor progression and respiratory failure in February 2014.

These 2 cases experienced nontraumatic bilateral AVN of the femoral heads, and one also had bilateral humeral head AVN. Both received chemotherapy and exhibited coagulopathy with a tumor or thrombus over the right pulmonary vein and left atrium. One also had multiple thromboembolic complications, including pulmonary obstructive syndrome [11] and paraneoplastic pain [12]. The other showed multiple paraneoplastic syndromes, including hypercalcemia and thrombocytosis.

The disruption of the blood supply to the hip and shoulder was due to arterial insufficiency in these areas, probably caused by paradoxical embolism [13, 14]. Paradoxical embolism is defined as the passage of a clot (thrombus) from a vein to an artery [11]. A tumor or thrombus was observed in the right pulmonary vein and left atrium in both cases. When a clot in a vein breaks off, it can lodge in an artery, causing localized ischemia. This can occur in the limbs, causing resting pain, as well as in the brain, causing a cerebral infarction [13, 14]. Claudication is defined as the pain caused by insufficient blood flow to an area, usually during exercise. This condition generally affects the legs, but can also affect the arms [15].

Thrombosis in arteries has long been recognized in cancer patients, although the exact mechanisms remain obscure [16]. A potential mechanism may be endothelial damage in the arterial wall, causing the loss of the blood’s natural anticoagulant properties [16, 17]. Virchow described three factors (venous stasis, endothelial injury, and hypercoagulability) that are thought to contribute to venous and arterial thrombosis [16]. The mechanism of the prothrombotic state is complex in cancer patients: cancer cells can activate the hemostatic system via the expression of adhesion molecules, the release of inflammatory cytokines, and the production of hemostatic factors [18]. Cytokine production is intricately related to both tumor production and the patient’s reaction to factors such as infection, chemotherapy, and invasive therapeutic procedures [19].

Both patients in this case study experienced multiple courses of chemotherapy, resulting in increased production of cytokines, which caused the formation of thrombi and decreased arterial blood supply. Blood disruption to the epiphyses of the femoral and humeral heads led to the development of AVN. The first case exhibited multiple thromboembolic complications, including pulmonary obstructive syndrome, dyspnea [11], and paraneoplastic migratory pain [12]. These cases were unusual, since AVN usually occurs in patients with hematological malignancies [20-22] and is rarely seen in cases with solid tumors [23].

After detection of the tumor or thrombus in the pulmonary vein and left atrium, both patients received regular scheduled chemotherapy, as well as continuous LMWH at the beginning of the chemotherapy course. The first case also received prolonged dexamethasone and intravenous fluid therapy in order to decrease cytokine production, because of multiple episodes of thromboembolic complications. There has been no benefit reported from using LMWH or oral anticoagulant treatment for intermittent claudication [24]. Both patients eventually received bilateral hip arthroplasty due to AVN of both femoral heads [25], and both died of cancer with coagulopathy: one from brain death and the other from respiratory failure.

Cancer patients with coagulopathy undergo chemotherapy and anticoagulant therapy. When they complain of groin pain and claudication, AVN of the femoral head should be the differential diagnosis.

The study was approved by the Chang Gung Medical Foundation.

Institutional Review Board IRB No.: 201701703B0.

The authors have no conflicts of interest to declare.

No funding was given for this case report.

1.
Kerachian
MA
,
Harvey
EJ
,
Cournoyer
D
,
Chow
TY
,
Séguin
C
.
Avascular necrosis of the femoral head: vascular hypotheses
.
Endothelium
.
2006
Jul-Aug
;
13
(
4
):
237
44
.
[PubMed]
1062-3329
2.
Shah
KN
,
Racine
J
,
Jones
LC
,
Aaron
RK
.
Pathophysiology and risk factors for osteonecrosis
.
Curr Rev Musculoskelet Med
.
2015
Sep
;
8
(
3
):
201
9
.
[PubMed]
1935-973X
3.
Tsai
SW
,
Wu
PK
,
Chen
CF
,
Chiang
CC
,
Huang
CK
,
Chen
TH
, et al.
Etiologies and outcome of osteonecrosis of the femoral head: etiology and outcome study in a Taiwan population
.
J Chin Med Assoc
.
2016
Jan
;
79
(
1
):
39
45
.
[PubMed]
1726-4901
4.
Mont
MA
,
Cherian
JJ
,
Sierra
RJ
,
Jones
LC
,
Lieberman
JR
.
Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today? A Ten-Year Update
.
J Bone Joint Surg Am
.
2015
Oct
;
97
(
19
):
1604
27
.
[PubMed]
0021-9355
5.
Etienne
G
,
Mont
MA
,
Ragland
PS
.
The diagnosis and treatment of nontraumatic osteonecrosis of the femoral head
.
Instr Course Lect
.
2004
;
53
:
67
85
.
[PubMed]
0065-6895
6.
Garcia
FL
,
Ramalli
EL
,
Picado
CH
.
Coagulation disorders in patients with femoral head osteonecrosis
.
Acta Ortop Bras
.
2013
Jan
;
21
(
1
):
43
5
.
[PubMed]
1413-7852
7.
Chan
KL
,
Mok
CC
.
Glucocorticoid-induced avascular bone necrosis: diagnosis and management
.
Open Orthop J
.
2012
;
6
:
449
57
.
[PubMed]
1874-3250
8.
Barbour
SY
.
Corticosteroids in the treatment of chemotherapy-induced nausea and vomiting
.
J Natl Compr Canc Netw
.
2012
Apr
;
10
(
4
):
493
9
.
[PubMed]
1540-1405
9.
Harreld
KL
,
Marker
DR
,
Wiesler
ER
,
Shafiq
B
,
Mont
MA
.
Osteonecrosis of the humeral head
.
J Am Acad Orthop Surg
.
2009
Jun
;
17
(
6
):
345
55
.
[PubMed]
1067-151X
10.
Virgolini
L
,
De Maglio
A
.
Bilateral aseptic necrosis of the humeral head following combined therapy for Hodgkin’s lymphoma
.
Ital J Orthop Traumatol
.
1992
;
18
(
4
):
543
6
.
[PubMed]
0390-5489
11.
Liaw
CC
,
Chang
H
,
Yang
TS
,
Wen
MS
.
Pulmonary venous obstruction in vancer patients
.
J Oncol
.
2015
;
2015
:
210916
.
[PubMed]
1687-8450
12.
Ripamonti
CI
,
Santini
D
,
Maranzano
E
,
Berti
M
,
Roila
F
.
Management of cancer pain: ESMO clinical recommendations
.
Ann Oncol
.
2012
Oct
;
23
Suppl 7
:
vii39
154
. 0923-7534
13.
Windecker
S
,
Stortecky
S
,
Meier
B
.
Paradoxical embolism
.
J Am Coll Cardiol
.
2014
Jul
;
64
(
4
):
403
15
.
[PubMed]
0735-1097
14.
Travis
JA
,
Fuller
SB
,
Ligush
J
 Jr
,
Plonk
GW
 Jr
,
Geary
RL
,
Hansen
KJ
.
Diagnosis and treatment of paradoxical embolus
.
J Vasc Surg
.
2001
Nov
;
34
(
5
):
860
5
.
[PubMed]
0741-5214
15.
Schainfeld
RM
.
Management of peripheral arterial disease and intermittent claudication
.
J Am Board Fam Pract
.
2001
Nov-Dec
;
14
(
6
):
443
50
.
[PubMed]
0893-8652
16.
Blann
AD
,
Dunmore
S
.
Arterial and venous thrombosis in cancer patients
.
Cardiol Res Pract
.
2011
Mar
;
2011
:
394740
.
[PubMed]
2090-0597
17.
Ross
JS
,
Stagliano
NE
,
Donovan
MJ
,
Breitbart
RE
,
Ginsburg
GS
.
Atherosclerosis: a cancer of the blood vessels?
Am J Clin Pathol.
2001
Dec;116 Suppl):S97-107
18.
Bagot
CN
,
Arya
R
.
Virchow and his triad: a question of attribution
.
Br J Haematol
.
2008
Oct
;
143
(
2
):
180
90
.
[PubMed]
0007-1048
19.
Falanga
A
,
Marchetti
M
,
Vignoli
A
.
Coagulation and cancer: biological and clinical aspects
.
J Thromb Haemost
.
2013
Feb
;
11
(
2
):
223
33
.
[PubMed]
1538-7933
20.
Hui
L
,
Wiernik
PH
.
Avascular necrosis of bone after adult acute lymphocytic leukemia treatment with methotrexate, vincristine, L-asparaginase, and dexamethasone (MOAD)
.
Am J Hematol
.
1996
Jul
;
52
(
3
):
184
8
.
[PubMed]
0361-8609
21.
Abhyankar
D
,
Nair
R
,
Menon
H
,
Kapoor
B
,
Advani
S
.
Avascular necrosis of head of femur in a patient with acute promyelocytic leukemia
.
Leuk Lymphoma
.
2000
May
;
37
(
5-6
):
635
7
.
[PubMed]
1042-8194
22.
Sakakura
M
,
Nishii
K
,
Usui
E
,
Monma
F
,
Tsukada
T
,
Shiku
H
.
Bilateral osteonecrosis of the head of the femur during treatment with retinoic acid in a young patient with acute promyelocytic leukemia
.
Int J Hematol
.
2006
Apr
;
83
(
3
):
252
3
.
[PubMed]
0925-5710
23.
van den Berkmortel
F
,
de Wit
R
,
de Rooy
J
,
DeMulder
P
.
Osteonecrosis in patients with testicular tumours treated with chemotherapy
.
Neth J Med
.
2004
Jan
;
62
(
1
):
23
7
.
[PubMed]
0300-2977
24.
Cosmi
B
,
Conti
E
,
Coccheri
S
.
Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication
.
Cochrane Database Syst Rev
.
2014
May
;
7
(
5
):
CD001999
.
[PubMed]
1469-493X
25.
Roth
A
,
Beckmann
J
,
Bohndorf
K
,
Fischer
A
,
Heiß
C
,
Kenn
W
, et al.
S3-Guideline non-traumatic adult femoral head necrosis
.
Arch Orthop Trauma Surg
.
2016
Feb
;
136
(
2
):
165
74
.
[PubMed]
0936-8051
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.